170 related articles for article (PubMed ID: 12019348)
1. Oncostatic action of melatonin: facts and question marks.
Pawlikowski M; Winczyk K; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
[TBL] [Abstract][Full Text] [Related]
2. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
4. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells.
Winczyk K; Lawnicka H; Pawlikowski M; Kunert-Radek J; Karasek M
Neuro Endocrinol Lett; 2006 Jun; 27(3):351-4. PubMed ID: 16816834
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
6. Melatonin: adjuvant therapy of malignant tumors.
Dziegiel P; Podhorska-Okolow M; Zabel M
Med Sci Monit; 2008 May; 14(5):RA64-70. PubMed ID: 18443563
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
8. Pineal gland, melatonin and cancer. NEL Review.
Karasek M; Pawlikowski M
Neuro Endocrinol Lett; 1999; 20(3-4):139-144. PubMed ID: 11462104
[TBL] [Abstract][Full Text] [Related]
9. Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer.
Karasek M; Carrillo-Vico A; Guerrero JM; Winczyk K; Pawlikowski M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():55-60. PubMed ID: 12019353
[TBL] [Abstract][Full Text] [Related]
10. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
11. Melatonin in cancer management: progress and promise.
Jung B; Ahmad N
Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of melatonin and CGP 52608.
Karasek M; Pawlikowski M
Biol Signals Recept; 1999; 8(1-2):75-8. PubMed ID: 10085466
[TBL] [Abstract][Full Text] [Related]
13. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling.
Wiesenberg I; Missbach M; Carlberg C
Restor Neurol Neurosci; 1998 Jun; 12(2-3):143-50. PubMed ID: 12671309
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits growth of diethylstilbestrol-induced prolactin-secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors.
Karasek M; Gruszka A; Lawnicka H; Kunert-Radek J; Pawlikowski M
J Pineal Res; 2003 May; 34(4):294-6. PubMed ID: 12662353
[TBL] [Abstract][Full Text] [Related]
16. Intracellular second messengers involved in melatonin signal transduction in chicken splenocytes in vitro.
Markowska M; Mrozkowiak A; Pawlak J; Skwarło-Sońta K
J Pineal Res; 2004 Oct; 37(3):207-12. PubMed ID: 15357666
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer.
Winczyk K; Pawlikowski M; Guerrero JM; Karasek M
Tumour Biol; 2002; 23(5):298-302. PubMed ID: 12595746
[TBL] [Abstract][Full Text] [Related]
18. Human pineal physiology and functional significance of melatonin.
Macchi MM; Bruce JN
Front Neuroendocrinol; 2004; 25(3-4):177-95. PubMed ID: 15589268
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA
J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272
[TBL] [Abstract][Full Text] [Related]
20. [Significance of melatonin in malignant diseases].
Bartsch C; Bartsch H
Wien Klin Wochenschr; 1997 Oct; 109(18):722-9. PubMed ID: 9441515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
